WEKO3
アイテム
{"_buckets": {"deposit": "6bfaffdc-06da-4ee1-900f-3519bcc62463"}, "_deposit": {"created_by": 1, "id": "82932", "owners": [1], "pid": {"revision_id": 0, "type": "depid", "value": "82932"}, "status": "published"}, "_oai": {"id": "oai:repo.qst.go.jp:00082932", "sets": ["28"]}, "author_link": ["994319", "994313", "994314", "994312", "994315", "994308", "994309", "994317", "994318", "994311", "994310", "994316"], "item_10005_date_7": {"attribute_name": "発表年月日", "attribute_value_mlt": [{"subitem_date_issued_datetime": "2021-06-11", "subitem_date_issued_type": "Issued"}]}, "item_10005_description_5": {"attribute_name": "抄録", "attribute_value_mlt": [{"subitem_description": "Objectives: Lung cancer is one of the most prevalent cancers worldwide, and non-small cell lung cancer (NSCLC) accounts for about 85-90% of all lung tumor types. Carbon ion radiation therapy (CIRT) has achieved outcomes comparable to surgery due to its excellent dose-concentration and high biological effectiveness.\nHowever, two-year progression-free survival of patients treated with CIRT for locally advanced lung cancer is reported as 40%. C11-methionine (MET) is an amino acid radiotracer known to show tumor-specific accumulation and MET-PET/CT imaging is useful in evaluating lung tumors. However, the correlation between MET-PET/CT imaging biomarkers and prognosis in NSCLC patients is still unknown. The aim of this study was to investigate the predictive values of MET-PET/CT in patients treated with CIRT for NSCLC.\nMethods: Sixty consecutive patients (36 males and 24 females; mean age 73.3y; range 51-89y) with locally advanced NSCLC who underwent MET-PET/CT prior to CIRT between 2007 and 2012 were enrolled. Patients were treated with 40-50 Gy of CIRT. The mean follow-up period was 77.3 months. For quantitative analysis of PET image data, metabolic tumor volume was obtained with a threshold of standardized sptake value (SUV) greater than 1.5. Tumor contouring on MET-PET/CT image was determined by a consensus of two board-certified diagnostic radiologists. Univariate and Multivariate Cox proportional hazard regression analyses and Kaplan-Meir analyses were performed to assess the predictive value for disease-free survival (DFS) among a diameter of solid tumor component (Solid-Diameter), SUVmax, Metabolic Tumor Volume (MTV), Total Lesion Metabolism of the amino acid (TLM), and clinical factors. Statistical analyses were calculated with SPSS statistical software, version 26 with P values of less than 0.05 considered statistically significant.\nResults: The mean SUVmax of the tumor was 3.53±1.0. Univariate Cox proportional hazard regression analyses showed that SUVmax (p\u003clt;0.05, HR 3.22 95% CI 1.21-8.56), MTV (p\u003clt;0.005, HR 4.45, 95% CI 1.78-11.2), and TLM (p\u003clt;0.005, HR 0.249, 95% CI 0.10-0.62) were significant prognostic factors for DFS. While, the Solid-Diameter, age, sex, and the treatment radiation dose were not significant prognostic factors for DFS. After checking multicollinearity, multivariate Cox hazard analysis was performed with five elements: Solid-Diameter, SUVmax, MTV, age, and sex. MTV was revealed to be the only independent prognostic factor (p\u003clt;0.05, HR 0.257, 95% CI 0.072-0.923). Kaplan-Meier analysis of MTV demonstrated that patients with MTV lower than 6ml had longer DFS (p\u003clt;0.001).\nConclusions: Metabolic Tumor Volume (thresholds of SUV 1.5) in MET-PET/CT would be a useful predictor of disease-free survival of NSCLC treated with CIRT.\n", "subitem_description_type": "Abstract"}]}, "item_10005_description_6": {"attribute_name": "会議概要(会議名, 開催地, 会期, 主催者等)", "attribute_value_mlt": [{"subitem_description": "SNMMI 2021 Annual Meeting", "subitem_description_type": "Other"}]}, "item_access_right": {"attribute_name": "アクセス権", "attribute_value_mlt": [{"subitem_access_right": "metadata only access", "subitem_access_right_uri": "http://purl.org/coar/access_right/c_14cb"}]}, "item_creator": {"attribute_name": "著者", "attribute_type": "creator", "attribute_value_mlt": [{"creatorNames": [{"creatorName": "Kentaro, Tamura"}], "nameIdentifiers": [{"nameIdentifier": "994308", "nameIdentifierScheme": "WEKO"}]}, {"creatorNames": [{"creatorName": "Ryuichi, Nishii"}], "nameIdentifiers": [{"nameIdentifier": "994309", "nameIdentifierScheme": "WEKO"}]}, {"creatorNames": [{"creatorName": "Kana, Yamazaki"}], "nameIdentifiers": [{"nameIdentifier": "994310", "nameIdentifierScheme": "WEKO"}]}, {"creatorNames": [{"creatorName": "Naoyoshi, Yamamoto"}], "nameIdentifiers": [{"nameIdentifier": "994311", "nameIdentifierScheme": "WEKO"}]}, {"creatorNames": [{"creatorName": "Tatsuya, Higashi"}], "nameIdentifiers": [{"nameIdentifier": "994312", "nameIdentifierScheme": "WEKO"}]}, {"creatorNames": [{"creatorName": "Hiroshi, Tsuji"}], "nameIdentifiers": [{"nameIdentifier": "994313", "nameIdentifierScheme": "WEKO"}]}, {"creatorNames": [{"creatorName": "Kentaro, Tamura", "creatorNameLang": "en"}], "nameIdentifiers": [{"nameIdentifier": "994314", "nameIdentifierScheme": "WEKO"}]}, {"creatorNames": [{"creatorName": "Ryuichi, Nishii", "creatorNameLang": "en"}], "nameIdentifiers": [{"nameIdentifier": "994315", "nameIdentifierScheme": "WEKO"}]}, {"creatorNames": [{"creatorName": "Kana, Yamazaki", "creatorNameLang": "en"}], "nameIdentifiers": [{"nameIdentifier": "994316", "nameIdentifierScheme": "WEKO"}]}, {"creatorNames": [{"creatorName": "Naoyoshi, Yamamoto", "creatorNameLang": "en"}], "nameIdentifiers": [{"nameIdentifier": "994317", "nameIdentifierScheme": "WEKO"}]}, {"creatorNames": [{"creatorName": "Tatsuya, Higashi", "creatorNameLang": "en"}], "nameIdentifiers": [{"nameIdentifier": "994318", "nameIdentifierScheme": "WEKO"}]}, {"creatorNames": [{"creatorName": "Hiroshi, Tsuji", "creatorNameLang": "en"}], "nameIdentifiers": [{"nameIdentifier": "994319", "nameIdentifierScheme": "WEKO"}]}]}, "item_language": {"attribute_name": "言語", "attribute_value_mlt": [{"subitem_language": "eng"}]}, "item_resource_type": {"attribute_name": "資源タイプ", "attribute_value_mlt": [{"resourcetype": "conference object", "resourceuri": "http://purl.org/coar/resource_type/c_c94f"}]}, "item_title": "Metabolic Tumor Volume of Methionine PET in Early Lung Cancer is Useful for Predicting Prognosis of Patients treated with Carbon Ion Radiotherapy", "item_titles": {"attribute_name": "タイトル", "attribute_value_mlt": [{"subitem_title": "Metabolic Tumor Volume of Methionine PET in Early Lung Cancer is Useful for Predicting Prognosis of Patients treated with Carbon Ion Radiotherapy"}]}, "item_type_id": "10005", "owner": "1", "path": ["28"], "permalink_uri": "https://repo.qst.go.jp/records/82932", "pubdate": {"attribute_name": "公開日", "attribute_value": "2021-06-04"}, "publish_date": "2021-06-04", "publish_status": "0", "recid": "82932", "relation": {}, "relation_version_is_last": true, "title": ["Metabolic Tumor Volume of Methionine PET in Early Lung Cancer is Useful for Predicting Prognosis of Patients treated with Carbon Ion Radiotherapy"], "weko_shared_id": -1}
Metabolic Tumor Volume of Methionine PET in Early Lung Cancer is Useful for Predicting Prognosis of Patients treated with Carbon Ion Radiotherapy
https://repo.qst.go.jp/records/82932
https://repo.qst.go.jp/records/82932dd60d130-bc6f-4372-8519-9521b17ad679
Item type | 会議発表用資料 / Presentation(1) | |||||
---|---|---|---|---|---|---|
公開日 | 2021-06-04 | |||||
タイトル | ||||||
タイトル | Metabolic Tumor Volume of Methionine PET in Early Lung Cancer is Useful for Predicting Prognosis of Patients treated with Carbon Ion Radiotherapy | |||||
言語 | ||||||
言語 | eng | |||||
資源タイプ | ||||||
資源タイプ識別子 | http://purl.org/coar/resource_type/c_c94f | |||||
資源タイプ | conference object | |||||
アクセス権 | ||||||
アクセス権 | metadata only access | |||||
アクセス権URI | http://purl.org/coar/access_right/c_14cb | |||||
著者 |
Kentaro, Tamura
× Kentaro, Tamura× Ryuichi, Nishii× Kana, Yamazaki× Naoyoshi, Yamamoto× Tatsuya, Higashi× Hiroshi, Tsuji× Kentaro, Tamura× Ryuichi, Nishii× Kana, Yamazaki× Naoyoshi, Yamamoto× Tatsuya, Higashi× Hiroshi, Tsuji |
|||||
抄録 | ||||||
内容記述タイプ | Abstract | |||||
内容記述 | Objectives: Lung cancer is one of the most prevalent cancers worldwide, and non-small cell lung cancer (NSCLC) accounts for about 85-90% of all lung tumor types. Carbon ion radiation therapy (CIRT) has achieved outcomes comparable to surgery due to its excellent dose-concentration and high biological effectiveness. However, two-year progression-free survival of patients treated with CIRT for locally advanced lung cancer is reported as 40%. C11-methionine (MET) is an amino acid radiotracer known to show tumor-specific accumulation and MET-PET/CT imaging is useful in evaluating lung tumors. However, the correlation between MET-PET/CT imaging biomarkers and prognosis in NSCLC patients is still unknown. The aim of this study was to investigate the predictive values of MET-PET/CT in patients treated with CIRT for NSCLC. Methods: Sixty consecutive patients (36 males and 24 females; mean age 73.3y; range 51-89y) with locally advanced NSCLC who underwent MET-PET/CT prior to CIRT between 2007 and 2012 were enrolled. Patients were treated with 40-50 Gy of CIRT. The mean follow-up period was 77.3 months. For quantitative analysis of PET image data, metabolic tumor volume was obtained with a threshold of standardized sptake value (SUV) greater than 1.5. Tumor contouring on MET-PET/CT image was determined by a consensus of two board-certified diagnostic radiologists. Univariate and Multivariate Cox proportional hazard regression analyses and Kaplan-Meir analyses were performed to assess the predictive value for disease-free survival (DFS) among a diameter of solid tumor component (Solid-Diameter), SUVmax, Metabolic Tumor Volume (MTV), Total Lesion Metabolism of the amino acid (TLM), and clinical factors. Statistical analyses were calculated with SPSS statistical software, version 26 with P values of less than 0.05 considered statistically significant. Results: The mean SUVmax of the tumor was 3.53±1.0. Univariate Cox proportional hazard regression analyses showed that SUVmax (p<lt;0.05, HR 3.22 95% CI 1.21-8.56), MTV (p<lt;0.005, HR 4.45, 95% CI 1.78-11.2), and TLM (p<lt;0.005, HR 0.249, 95% CI 0.10-0.62) were significant prognostic factors for DFS. While, the Solid-Diameter, age, sex, and the treatment radiation dose were not significant prognostic factors for DFS. After checking multicollinearity, multivariate Cox hazard analysis was performed with five elements: Solid-Diameter, SUVmax, MTV, age, and sex. MTV was revealed to be the only independent prognostic factor (p<lt;0.05, HR 0.257, 95% CI 0.072-0.923). Kaplan-Meier analysis of MTV demonstrated that patients with MTV lower than 6ml had longer DFS (p<lt;0.001). Conclusions: Metabolic Tumor Volume (thresholds of SUV 1.5) in MET-PET/CT would be a useful predictor of disease-free survival of NSCLC treated with CIRT. |
|||||
会議概要(会議名, 開催地, 会期, 主催者等) | ||||||
内容記述タイプ | Other | |||||
内容記述 | SNMMI 2021 Annual Meeting | |||||
発表年月日 | ||||||
日付 | 2021-06-11 | |||||
日付タイプ | Issued |